City

Philadelphia (2)

Portland (1)

Overall Status

Recruiting (3)

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Thomas Jefferson University (2)

OHSU Knight Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (1)

Oregon Health and Science University (1)

Study Documents

Intervention Type

drug (2)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stage 0 pancreatic cancer ajcc v8

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage

Recruiting

Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
+85 more

Patient Monitoring System
+2 more

Philadelphia, Pennsylvania

Thomas Jefferson University Hospital

Sep 7, 2022

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting

Borderline Resectable Pancreatic Carcinoma
+8 more

Capecitabine
+7 more

Portland, Oregon

OHSU Knight Cancer Institute

Aug 25, 2022

Resectable Pancreatic Ductal Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8 Trial in

Recruiting

Resectable Pancreatic Ductal Adenocarcinoma
+7 more

Pyrvinium Pamoate

Philadelphia, Pennsylvania

Thomas Jefferson University

Aug 1, 2022